46
total announcements
VIVOBIOT.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 06 Nov 2026
Market Cap
₹33 Cr
EPS (TTM)
₹-1.43
52W Low
₹12.00
52W High
₹20.44
Dividend Yield
0.00%
Beta
0.40
Price / Book
0.3
Debt / Equity
72.3
Revenue (TTM)
₹55 Cr
Gross Margin
84.61%
Operating Margin
10.65%
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Dwight Technologies Pvt Ltd.
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from P K L Solution Pvt Ltd.
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd has announced the re-appointment of three Whole-time Directors, Mr. Kalyan Ram Mangipudi, Mr. Sri Kalyan Kompella, and Dr. Sankaranarayanan Alangudi, for a period of 5 years, subject to shareholder approval.
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd has announced the outcome of its Board Meeting, approving the re-appointment of three Whole-time Directors, including Mr. Kalyan Ram Mangipudi, Mr. Sri Kalyan Kompella, and Dr. Sankaranarayanan Alangudi, for a period of 5 years, subject to shareholder approval.
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd has informed BSE that 8,10,000 convertible equity warrants issued to promoters on February 21, 2025, have expired due to non-exercise before the completion of the tenure of eighteen months.
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd has informed the BSE that 483 out of 26,00,000 convertible equity warrants issued on February 20, 2025, have expired due to non-exercise before the completion of the tenure of eighteen months.